SPRY

$0.00

(

+0.00%

)
Quote details

stock

ARS Pharmaceuticals, Inc

NASDAQ | SPRY

10.70

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 8, 2025)

$995.18M

Market Cap

-

P/E Ratio

-0.48

EPS

$18.89

52 Week High

$9.97

52 Week Low

HEALTHCARE

Sector

SPRY Chart

Recent Chart
Price Action

SPRY Technicals

Tags:

SPRY Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $88M
Total Revenue $89M
Cost Of Revenue $977K
Costof Goods And Services Sold $977K
Operating Income -$3.1M
Selling General And Administrative $72M
Research And Development $20M
Operating Expenses $91M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $208K
Income Before Tax $8.3M
Income Tax Expense $288K
Interest And Debt Expense -
Net Income From Continuing Operations $8M
Comprehensive Income Net Of Tax -
Ebit -$3.1M
Ebitda -$2.9M
Net Income $8M

Revenue & Profitability

Earnings Performance

SPRY Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $351M
Total Current Assets $334M
Cash And Cash Equivalents At Carrying Value $51M
Cash And Short Term Investments $51M
Inventory $5.2M
Current Net Receivables $9.2M
Total Non Current Assets $17M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $7.7M
Intangible Assets Excluding Goodwill $7.7M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $263M
Other Current Assets $5.9M
Other Non Current Assets -
Total Liabilities $94M
Total Current Liabilities $23M
Current Accounts Payable $9.9M
Deferred Revenue -
Current Debt -
Short Term Debt $42K
Total Non Current Liabilities $71M
Capital Lease Obligations $42K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $42K
Other Current Liabilities $13M
Other Non Current Liabilities $69M
Total Shareholder Equity $257M
Treasury Stock -
Retained Earnings -$123M
Common Stock $10K
Common Stock Shares Outstanding $102M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $14M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -$7.2M
Capital Expenditures $563K
Change In Receivables -
Change In Inventory -$5.9M
Profit Loss -
Cashflow From Investment -$106M
Cashflow From Financing $72M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $8M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $88M
Total Revenue $89M
Cost Of Revenue $977K
Costof Goods And Services Sold $977K
Operating Income -$3.1M
Selling General And Administrative $72M
Research And Development $20M
Operating Expenses $91M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $208K
Income Before Tax $8.3M
Income Tax Expense $288K
Interest And Debt Expense -
Net Income From Continuing Operations $8M
Comprehensive Income Net Of Tax -
Ebit -$3.1M
Ebitda -$2.9M
Net Income $8M

SPRY News

SPRY Profile

ARS Pharmaceuticals, Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine aerosol with absorption technology for patients and their families at risk of severe allergic reactions to food, medication, and insect stings. The company is headquartered in San Diego, California.

NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-1.02%
$18.43
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
YAAS
-21.16%
$0.08
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
T
-2.33%
$28.90
MGIH
+42.13%
$2.25
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
NCLH
-4.40%
$24.53
GOOGL
-0.31%
$234.04
WULF
+0.76%
$9.19
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
NOK
+0.87%
$4.59
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
PT
+17.89%
$1.12
RIG
+2.93%
$3.16
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.50%
$16.79
RGTI
+0.33%
$15.15
CRWV
+5.00%
$93.55
MRVL
+4.21%
$66.00
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
MULN
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32
QBTS
+0.32%
$15.42
NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-1.02%
$18.43
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
YAAS
-21.16%
$0.08
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
T
-2.33%
$28.90
MGIH
+42.13%
$2.25
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
NCLH
-4.40%
$24.53
GOOGL
-0.31%
$234.04
WULF
+0.76%
$9.19
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
NOK
+0.87%
$4.59
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
PT
+17.89%
$1.12
RIG
+2.93%
$3.16
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.50%
$16.79
RGTI
+0.33%
$15.15
CRWV
+5.00%
$93.55
MRVL
+4.21%
$66.00
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
MULN
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32
QBTS
+0.32%
$15.42

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.